Nom du produit:N-(4-(2-Methylimidazo[1,2-a]pyridin-3-yl)pyrimidin-2-yl)acetamide
IUPAC Name:N-(4-{2-methylimidazo[1,2-a]pyridin-3-yl}pyrimidin-2-yl)acetamide
- CAS：611239-38-4
- Formule moléculaire：C14H13N5O
- Pureté：97%
- Numéro de catalogue：CM288845
- Poids moléculaire：267.29
| Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:611239-38-4
- Formule moléculaire:C14H13N5O
- Point de fusion:-
- Code SMILES:CC(NC1=NC=CC(C2=C(C)N=C3C=CC=CN32)=N1)=O
- Densité:
- Numéro de catalogue:CM288845
- Poids moléculaire:267.29
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Imidazopyridines
- With four imidazopyridine-containing drugs and one pyrazolopyridine-containing drug on the market, bicyclic pyridines containing ring-junction nitrogen are privileged structures in medicinal chemistry. With two nitrogen atoms with potential to serve as hydrogen bond acceptors, imidazopyridines and pyrazolopyridines may boost binding to target proteins and elevate potency. In addition, these structures have found utility in FBDD, covalent inhibitors, reducing metabolic liabilities, and creating novel chemical space and intellectual properties. With many of the advanced intermediates now commercially available, they will find more and more applications in drug discovery.
- imidazole pyridine supplier
- As a imidazole pyridine supplier,we will offer our best price with good quality for you.
- Pyrimidines
- Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.
Recherche 
+86 21 5895 0110 
